. FYI - The Visa interlocutory costs hearing that was set down for this Friday 24/2, has now been rescheduled to be heard after the trial on Tuesday the 21st March. Cheers .
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%